Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Journal of Neuroscience Methods|December 26, 2021
Two engineered AAV capsid variants for efficient transduction of human cortical neurons directly converted from iPSCSandra Fischer, Benjamin Strobel, Jonas Weinmann, et al.Human Gene Therapy Methods|July 30, 2015
Comparative Analysis of Cesium Chloride- and Iodixanol-Based Purification of Recombinant Adeno-Associated Viral Vectors for Preclinical ApplicationsBenjamin Strobel, Felix D Miller, Wolfgang Rist, et al.Molecular Therapy. Methods & Clinical Development|May 16, 2022
MSD-based assays facilitate a rapid and quantitative serostatus profiling for the presence of anti-AAV antibodiesJanina Haar, Dragica Blazevic, Benjamin Strobel, et al.Molecular Therapy. Methods & Clinical Development|July 1, 2025
AAV yield, bioactivity, and particle heterogeneity are impacted by genome size and non-coding DNA elementsGina Blahetek, Benjamin Lindner, Martin Oti, et al.Molecular Therapy. Methods & Clinical Development|July 17, 2024
Suppression of toxic transgene expression by optimized artificial miRNAs increases AAV vector yields in HEK-293 cellsGina Blahetek, Christine Mayer, Johannes Zuber, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2015
Riboswitch-mediated Attenuation of Transgene Cytotoxicity Increases Adeno-associated Virus Vector Yields in HEK-293 CellsBenjamin Strobel, Benedikt Klauser, Jörg S Hartig, et al.Scientific Reports|July 16, 2022
Time and phenotype-dependent transcriptome analysis in AAV-TGFβ1 and Bleomycin-induced lung fibrosis modelsBenjamin Strobel, Holger Klein, Germán Leparc, et al.Scientific Reports|March 10, 2017
Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosisVerena Aumiller, Benjamin Strobel, Merrit Romeike, et al.Molecular Therapy. Advances|July 12, 2026
AAV-norrin gene therapy rescues retinal defects in mice with Norrie disease and oxygen-induced retinopathyAndrea E Dillinger, Herbert Jaegle, Holger Fuchs, et al.Scientific Reports|November 10, 2022
Rosa26-LSL-dCas9-VPR: a versatile mouse model for tissue specific and simultaneous activation of multiple genes for drug discoveryDalia Pakalniškytė, Tanja Schönberger, Benjamin Strobel, et al.Pageof 4